The rising interest in GLP-1 agonists for diabetes has generated a question about application forms : skin-applied devices versus tablets . Usually , GLP-1 treatments were solely available in tablet form, https://majapzpe905997.wssblogs.com/40869638/glp-1-transdermal-delivery-systems-vs-oral-medications-what-right-for-the-patient